Company intelligence / Profile preview
Tremeau Pharmaceuticals
Concord, Massachusetts, United Statestremeau.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
Tremeau Pharmaceuticals focuses on developing non-opioid therapies for patients with significant unmet needs in pain management. Their lead asset TRM‑201 (rofecoxib) demonstrated comparable exposure at lower doses than historical VIOXX and has a differentiated safety profile. A Phase 3 trial in joint disorders was terminated due to low enrollment; the company continues development for acute pain indications. They are also advancing TRM‑362 (deuterated etoricoxib), which has shown promising pharmacokinetics in preclinical studies
- Therapeutic areas
- HematologyNeurologyRheumatology
- Modalities
- Small molecules (primarily COX-2 selective NSAIDs such as rofecoxib and deuterated etoricoxib)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
No major disclosed pharma/biotech partnerships; backed by Gurnet Point Capital
Beyond the preview
Go deeper on Tremeau Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tremeau Pharmaceuticals.